The secret of how the cold sore virus (herpes simplex virus 1) manages to persist for a lifetime in the human body may have been cracked by US scientists. – Now that Duke University Medical Center scientists have figured out how the virus that causes cold sores hides out, they may have a way to wake it up and kill it.
A strain of malaria thought previously to be ?benign? has been found to be potentially fatal in a recent study. – Plasmodium vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in PLoS Medicine this week. These findings challenge the current dogma that P. falciparum can be severe and life-threatening whereas Plasmodium vivax tends to be mild, according to the related commentary by Stephen Rogerson (University of Melbourne, Australia), an expert not connected with these studies.
A new avenue to possibly prevent HIV infection of the penis – topical estrogen to the human penis increased the thickness of the natural keratin layer on the skin, which could prevent HIV from infecting the male. – Topical oestrogen applied to the human penis could stop the spread of HIV, revealed by Australian researchers at the University of Melbourne.
New research into the causes of cervical cancer appears to lend weight to the promise of a potential early detection method that could help prevent the disease. – Persistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide, revealed by researchers from the University of North Carolina at Chapel Hill.
New ‘OPAL Therapy’ presents simple, cost-effective method of treating HIV infection – Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.
Expansion of a monocyte subset in HIV patients could serve as a biomarker for progression of the disease. – An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University, reported in the March issue of AIDS Research and Human Retroviruses.
Canadian researchers at the University of Alberta have discovered a gene that can block HIV, and in turn prevent the onset of AIDS. – Researchers at the University of Alberta have discovered a gene that is able to block HIV, and in turn prevent the onset of AIDS. Stephen Barr, a molecular virologist in the Department of Medical Microbiology and Immunology, says his team has identified a gene called TRIM22 that can block HIV infection in a cell culture by preventing the assembly of the virus.
Trial finds tenofovir gel safe for daily use and most women adhered to study regimens; Results of Phase II study of ARV-based microbicide presented at international meeting in India bolster interest in latest approach – A vag inal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.
A gel using anti-HIV drug tenofovir to shield women from AIDS has been proven safe for daily use and acceptable to women. – An experimental anti HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.
Growth hormone (GH) treatment was found to increase the immunity in HIV patients. It increased the thymic mass, and increased the number of immune cells HIV patients had circulating in their blood. – Growth hormone helps boost the immune system of HIV patients, revealed by researchers. Growth hormone (GH) treatment was associated with increased thymic mass, and increased the number of immune cells HIV patients had circulating in their blood.
Researchers have developed an inexpensive copper-based filter that may prevent HIV from being passed through breast milk and blood. – Researchers from the U.S. and abroad have developed an inexpensive copper-based filter that may prevent HIV from being passed through breast milk and blood. They report their findings in the February 2008 issue of the journal Antimicrobial Agents and Chemotherapy.
A study published in PLoS Medicine this week suggests that of women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy. – Women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy, revealed by researchers.
